ZAMO', Alberto
 Distribuzione geografica
Continente #
NA - Nord America 8.367
EU - Europa 7.432
AS - Asia 5.211
SA - Sud America 585
AF - Africa 138
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 1
Totale 21.762
Nazione #
US - Stati Uniti d'America 8.234
RU - Federazione Russa 2.557
SG - Singapore 2.102
GB - Regno Unito 1.688
CN - Cina 1.673
IT - Italia 704
DE - Germania 459
FR - Francia 458
SE - Svezia 456
VN - Vietnam 448
BR - Brasile 445
FI - Finlandia 393
HK - Hong Kong 372
IE - Irlanda 281
KR - Corea 165
UA - Ucraina 143
CA - Canada 90
IN - India 77
BD - Bangladesh 62
TR - Turchia 62
BE - Belgio 61
JP - Giappone 57
NG - Nigeria 57
AR - Argentina 55
NL - Olanda 47
ES - Italia 39
PL - Polonia 35
ID - Indonesia 33
ZA - Sudafrica 32
MX - Messico 27
IQ - Iraq 24
EC - Ecuador 20
IR - Iran 20
LT - Lituania 18
AU - Australia 17
CL - Cile 17
AT - Austria 16
PK - Pakistan 16
CO - Colombia 15
VE - Venezuela 14
RO - Romania 12
IL - Israele 11
NP - Nepal 11
UZ - Uzbekistan 10
CH - Svizzera 9
PH - Filippine 9
AZ - Azerbaigian 8
EG - Egitto 8
JO - Giordania 8
KE - Kenya 8
CZ - Repubblica Ceca 7
DZ - Algeria 7
AL - Albania 6
MA - Marocco 6
MY - Malesia 6
HR - Croazia 5
JM - Giamaica 5
PE - Perù 5
PY - Paraguay 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BG - Bulgaria 4
BO - Bolivia 4
CI - Costa d'Avorio 4
EE - Estonia 4
ET - Etiopia 4
KZ - Kazakistan 4
LV - Lettonia 4
RS - Serbia 4
SA - Arabia Saudita 4
UY - Uruguay 4
EU - Europa 3
GR - Grecia 3
HU - Ungheria 3
KG - Kirghizistan 3
LB - Libano 3
LU - Lussemburgo 3
PS - Palestinian Territory 3
SI - Slovenia 3
TH - Thailandia 3
TN - Tunisia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CY - Cipro 2
GE - Georgia 2
GT - Guatemala 2
LA - Repubblica Popolare Democratica del Laos 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AQ - Antartide 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CR - Costa Rica 1
DK - Danimarca 1
Totale 21.743
Città #
Southend 1.480
Singapore 1.164
Jacksonville 992
Moscow 867
Chandler 824
Dallas 729
Ashburn 720
San Jose 640
Woodbridge 524
Ann Arbor 466
Hong Kong 364
Beijing 299
Dublin 281
Houston 274
Verona 244
The Dalles 187
Council Bluffs 162
Wilmington 157
Ho Chi Minh City 148
New York 148
Lawrence 143
Princeton 143
Los Angeles 141
Jinan 121
Nanjing 119
Hanoi 103
Shenyang 91
Munich 90
Helsinki 89
Tianjin 72
Hebei 70
Buffalo 69
Sindelfingen 67
Brussels 60
Boardman 56
Ningbo 56
Nanchang 54
Columbus 53
Abuja 51
Turku 50
Tokyo 49
Orem 47
Milan 44
Haikou 41
Zhengzhou 40
Santa Clara 37
Changsha 36
Montreal 36
Hangzhou 34
Taizhou 34
Guangzhou 33
Jiaxing 33
Redondo Beach 33
Dearborn 32
São Paulo 31
Chicago 30
Frankfurt am Main 30
Bologna 27
Taiyuan 27
Warsaw 27
San Francisco 25
Fairfield 24
Stockholm 24
Norwalk 23
Denver 22
Rome 22
Seoul 22
Atlanta 21
Johannesburg 21
Lancaster 21
Phoenix 21
Redmond 21
Chennai 20
Groningen 19
Haiphong 19
Brooklyn 18
Falls Church 18
London 18
Toronto 18
Falkenstein 17
Madrid 17
Paris 17
Amsterdam 16
Fuzhou 15
Jakarta 15
Rio de Janeiro 15
Seattle 14
Brasília 13
Da Nang 13
Mexico City 13
Redwood City 13
Washington 13
Manchester 12
Boston 11
Curitiba 11
Dongguan 11
Düsseldorf 11
Kent 11
Leawood 11
Belo Horizonte 10
Totale 13.745
Nome #
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 333
Leucemia linfatica cronica/linfoma linfocitico (LLC): l'espressione di ZAP-70, analizzata alla diagnosi su biopsia ossea, è un importante fattore prognostico 306
B-cell chronic lymphocytic leukemia cells espress functional death receptor 3 following stimulation of the B cell receptor 267
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 262
Endothelin-1 receptor blockade as new possible therapeutic approach in multiple myeloma. 239
EXPRESSION AND FUNCTIONAL ACTIVITY OF DEATH RECEPTOR 3 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 237
Chromium-induced diffuse dermatitis with lymph node involvement resulting from Langerhans cell histiocytosis after metal-on-metal hip resurfacing 236
Detection of allele-specific gene expression on next generation sequencing data 234
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 233
Analysis of colorectal cancers for human cytomegalovirus presence 232
Application of a commercial software to the analysis of infrared structural images on lymph node tissues: a preliminary study 231
slan+ monocytes and macrophages mediate CD20-dependent B cell lymphoma elimination via ADCC and ADCP 231
[Primary large B cell non-Hodgkin's lymphoma of the mediastinum] 228
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 227
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 226
Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma. 225
Espressione di TP73L nei linfomi B a grandi cellule primitivi del mediastino: un utile marcatore diagnostico 219
CD10 is expressed in a subset of chromophobe renal cell carcinomas 218
ALK-positive anaplastic large cell lymphoma with PAX-5 expression: report of a case 216
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 216
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 214
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 212
Espressione di marcatori di migrazione e invasività nei foci fibroblastici nella fibrosi polmonare idiopatica 211
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 211
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant 211
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis 209
A Rare Disorder in an Orphan Disease: Kikuchi Fujimoto Disease in a Young-Adult Patient with Sickle Cell Anemia 204
Improvement of maternal and fetal outcomes in women with sickle cell disease treated with early prophylactic erythrocytapheresis 202
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 199
Hairy cell leukemia in kidney transplantation: lesson from a rare disorder. 196
Mantle cell lymphoma cell lines show no evident immunoglobulin heavy chain stereotypy but frequent light chain stereotypy 195
Microfluidic Deletion/Insertion Analysis for Rapid Screening of KIT and PDGFRA Mutations in CD117-Positive Gastrointestinal Stromal Tumors: Diagnostic Applications and Report of a New KIT Mutation. 195
Haploidentical hematopoietic stem cell transplantation in a myelofibrosis patient with primary graft failure 195
In reply to Schäfer et al: new evidence on the role of endothelin-1 axis as a potential therapeutic target in multiple myeloma 193
The TNF-Family Cytokine TL1A Inhibits Proliferation of Human Activated B Cells 190
Application of Microfluidic Technology to the BIOMED-2 Protocol for Detection of B-Cell Clonality 188
A 6-GENE EXPRESSION SIGNATURE IN MANTLE CELL LYMPHOMA: RESULTS FROM THE FONDAZIONE ITALIANA LINFOMI (FIL)-MCL-0208 TRIAL 186
FPA micro spectral imaging of non-Hodgkin lymphomas 183
The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis 182
EXPRESSION AND FUNCTIONAL ACTIVITY OF THE TNFR-SUPERFAMILY MEMBER DEATH RECEPTOR 3 IN CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS ACTIVATED BY THE BCR 181
MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways 177
Evaluation of S-phase fraction as a prognostic marker in mantle cell lymphoma 175
Utilizzo di un apparato microfluidico per il rilevamento del riarrangiamento clonale dei geni delleimmunoglobuline secondo il protocollo BIOMED-2 174
Establishment of the MAVER -1 cell line, a model for leukemic and aggressive mantle cell lymphoma. 174
Use of a Chip-based microfluidic apparatus in the analytic step of the Biomed-2 protocol for the detection of B-cell clonality 171
The role of disease causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL. 171
ALK-mediated activation of STAT3 elicits growth and anti-apoptotic signals. 170
Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling. 170
PEROXIREDOXIN-2: A NOVEL REGULATOR OF IRON HOMEOSTASIS IN INEFFECTIVE ERYTHROPOIESIS 170
Induction of apoptosis in Jeko-1 mantle cell lymphoma cell line by resveratrol: a proteomic analysis. 169
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathway as a potential therapeutic target. 168
ATM Deficiency Sensitizes Mantle Cell Lymphoma Cells to Poly(ADP-Ribose) Polymerase-1 Inhibitors 168
In Vitro and In Vivo Model of EBV-Positive Non-Hodgkin Plasmablastic Lymphoma with Focal Plasmacytic Differentiation 168
HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis 165
An unusual case of sarcoidosis in an adult patient with sickle cell disease: Management with methotrexate and low dose of steroid 165
Short-term, intensive chemotherapy regimen is equally effective in Burkitt lymphoma (BL) and in the novel WHO 2008 entity “B-cell lymphoma intermediate between DLBCL and BL". 165
Signal transduction pathways of mantle cell lymphoma: a phosphoproteome-based study. 165
Activated KIT hyperexpression in thymic carcinoma: a potential target for therapeutic intervention. 163
Identification of the core phosphoproteome of mantle cell lymphoma cell lines 163
Constitutive expression of DeltaN-p63alpha isoform in human thymus and thymic epithelial tumours 162
The TNF-Family Cytokine TL1A/Death Receptor 3 System Reduces Metabolic Activity in Chronic Lymphocytic Leukemia B Cells 162
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathwayn as a potential therapeutic target 160
THE TNF-FAMILY CYTOKINE TL1A/DEATH RECEPTOR 3 FUNCTIONAL AXIS MODULATES B- CELL CHRONIC LYMPHOCYTIC LEUKEMIA PROLIFERATION 160
Classical Hodgkin lymphoma cells may promote an IL-17-enriched microenvironment 160
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death 159
Tissue proteomics of splenic marginal zone lymphoma 158
GREY ZONES OF HODGKIN LYMPHOMA: REPORT OF A CASE WITH FEATURES INTERMEDIATE BETWEEN PRIMARY MEDIASTINAL B-CELL LYMPHOMA, CLASSICAL HODGKIN LYMPHOMA AND NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA 157
Application of a commercial software to the analysis of infrared spectral images on lymph node tissues: a preliminary study. 154
Modified HyperCVAD and rituximab for the treatment of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. 154
Utilizzo dell'analisi microfluidica per il rilevamento di mutazioni dei geni KIT e PDGFRA nei tumori dello stroma gastroenterico. 152
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis 152
Group 3 innate lymphoid cells regulate neutrophil migration and function in human decidua 152
PHOSPHOSCAN ANALYSIS OF MANTLE CELL LYMPHOMA CELL LINES 151
Anaplastic lymphoma kinase in human cancer 148
Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis 147
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 145
Anaplastic large-cell lymphoma 142
VR09 Cell Line: An EBV-Positive Lymphoblastoid Cell Line with In Vivo Characteristics of Diffuse Large B Cell Lymphoma of Activated B-Cell Type 142
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases 142
CD16 expression in T-cell lymphomas: analysis on paraffin embedded tissues using the 2H7 antibody. 139
Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer. 139
Resveratrol activity on MCL cell line jeko-1: a proteomic approach 139
The mantle cell lymphoma website: a free web-based resource for mantle cell lymphoma researchers 139
Metodi e tecniche dell'anatomia patologica 134
Precise sequance analysis of rearranged immunoglobulin genes in mantle cell lymphoma cell lines 134
MicroRNA signatures and Foxp3+ cell count correlate with relapse occurrence in follicular lymphoma 133
VDJSeq-Solver: In Silico V(D)J Recombination Detection Tool 129
HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis 128
Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas 127
Phosphoproteome profiling of mantle cell lymphoma cell lines 126
Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas 124
The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion 124
Identification of a three-gene model as a powerful diagnostic tool for the recognition of ALK negative ALCL 123
Genome-Wide Promoter Methylation Profiling Of Splenic Marginal Zone Lymphoma (SMZL) Identifies Two Subgroups Of Patients With Distinct Genetic and Biologic Features and Different Outcomes 121
Impacts: planning a European initiative for standardized protein analysis of archival clinical tissues 119
Models for quantitative individual grading and prognosis in breast malignancies 118
Induction of apoptosis in Jeko-1 mantle cell lymphoma cell line by resveratrol : a proteomic analysis 118
Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole exome sequencing 118
TCL1A expression in marginal zone lymphoma: a clinico-pathological evaluation in paired spleen and bone marrow samples 115
Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma 115
Totale 17.705
Categoria #
all - tutte 69.799
article - articoli 38.731
book - libri 0
conference - conferenze 29.925
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.143
Totale 139.598


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202147 0 0 0 0 0 0 0 0 0 0 0 47
2021/20221.198 99 398 5 96 44 28 13 76 47 41 105 246
2022/20232.380 174 241 248 438 223 523 16 141 275 20 53 28
2023/20241.095 59 102 78 145 132 178 42 74 15 48 146 76
2024/20252.799 135 230 87 474 122 78 132 89 468 172 251 561
2025/20268.282 590 489 672 1.329 2.024 584 718 409 634 494 149 190
Totale 21.886